Stocks · Korea
376270
KOSDAQ
HEM Pharma
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-07 basis
Returns and 52-week range
1W+3.04%
1M-11.14%
3M-18.21%
6M-55.10%
1Y+37.53%
YTD-28.03%
52W high97,500원
52W low25,800원
From 52W high-65.23%
Financial results (consolidated)
| Period | Revenue | Operating income | Net income | OP margin |
|---|---|---|---|---|
| 2025 | 130억 | -156억 | -237억 | -120.1% |
| Quarterly | ||||
| 2025 1Q | 35억 | -24억 | -23억 | -67.4% |
| 2025 2Q | 28억 | -29억 | -33억 | -102.1% |
| 2025 3Q | 30억 | -36억 | -35억 | -120.4% |
| 2025 4Q | 37억 | -68억 | -146억 | -184.1% |
| 2026 1Q | 49억 | -38억 | -40억 | -77.8% |
Company
Address: 경기도 수원시 영통구 창룡대로256번길 50 711호
Peers in the same sector
Recent filings
- 2026-08-21반기보고서 (2026.06)
- 2026-08-06주요사항보고서(전환사채권발행결정) Major
- 2026-07-29[기재정정]사업보고서 (2025.12)
- 2026-06-19[기재정정]주요사항보고서(전환사채권발행결정) Major
- 2026-05-11분기보고서 (2026.03)
Source: DART (Financial Supervisory Service electronic disclosure)
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.